Finding new ways to improve immunotherapy for celiac disease.
SCREENING FOR TOLEROGENIC ADJUVANTS TO ENHANCE ANTIGEN SPECIFIC IMMUNOTHERAPY FOR CELIAC DISEASE.
This study is looking for new ways to help people with celiac disease by finding better treatments that work with the immune system to make it easier for them to handle gluten in their diets.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Qrono, INC NIH-funded |
| Lab location | 1 site (Pittsburgh, United States) |
| Project ID | NIH-10933263 on NIH RePORTER |
What this research studies
This research focuses on celiac disease, an autoimmune disorder triggered by gluten in foods like wheat, barley, and rye. The team is investigating how to enhance immunotherapy by discovering new tolerogenic adjuvants that can be combined with gluten antigens. By targeting specific immune cells, such as dendritic cells and macrophages, the goal is to develop a treatment that could help patients manage their condition more effectively. This approach aims to create a clinically viable option for those suffering from celiac disease.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with celiac disease who are seeking new treatment options.
Not a fit: Patients who do not have celiac disease or those who are not affected by gluten intolerance may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a groundbreaking immunotherapy that helps patients with celiac disease tolerate gluten better.
How similar studies have performed: While the approach of using tolerogenic adjuvants is innovative, similar strategies in other autoimmune conditions have shown promise, suggesting potential for success.
Where this research is happening
Pittsburgh, United States
- Qrono, INC — Pittsburgh, United States (Active)
Researchers
- Principal investigator: Cargill, Christina — Qrono, INC
- Study coordinator: Cargill, Christina
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.